These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2801723)

  • 1. Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions.
    Strong DK; Ho W; Nairn JG
    Am J Hosp Pharm; 1989 Sep; 46(9):1832-3. PubMed ID: 2801723
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy.
    Robinson JL; Tawfik G; Saxinger L; Stang L; Etches W; Lee B
    J Antimicrob Chemother; 2005 Nov; 56(5):951-3. PubMed ID: 16155063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of vancomycin hydrochloride in peritoneal dialysis solution.
    Mawhinney WM; Adair CG; Gorman SP; McClurg B
    Am J Hosp Pharm; 1992 Jan; 49(1):137-9. PubMed ID: 1570857
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility of heparin sodium and morphine sulfate.
    Baker DE; Yost GS; Craig VL; Campbell RK
    Am J Hosp Pharm; 1985 Jun; 42(6):1352-5. PubMed ID: 4014252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of haloperidol lactate and heparin sodium.
    Solomon DA; Nasinnyk KK
    Am J Hosp Pharm; 1982 May; 39(5):843-4. PubMed ID: 7081260
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of peritoneal dialysis solutions.
    Crawford-Bonadio TL; Diaz-Buxo JA
    Nephrol Nurs J; 2004; 31(5):499-507, 520; quiz 508-9. PubMed ID: 15518252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of cibenzoline succinate with commonly used acute-care medications.
    Dahl JM; Roche VF; Hilleman DE
    Am J Hosp Pharm; 1987 May; 44(5):1123-5. PubMed ID: 3605123
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient.
    Goedecke VA; Clajus C; Burkhardt O; Martens-Lobenhoffer J; Bode-Boger SM; Kielstein JT; Hiss M
    Scand J Infect Dis; 2009; 41(2):155-7. PubMed ID: 19085620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement].
    Olszowska A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):364-7. PubMed ID: 18634375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions.
    Wu CC; Wang DP; Wong CY; Lin YF
    Am J Health Syst Pharm; 2002 Aug; 59(16):1537-8. PubMed ID: 12185829
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of ceftizoxime sodium in four electrolyte injections.
    Swenson E; Gooch WM; Higbee MD
    Am J Hosp Pharm; 1986 Sep; 43(9):2242-4. PubMed ID: 3766586
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of narcotic analgesics with selected intravenous admixtures.
    Smythe MA; Patel MA; Gasloli RA
    Am J Hosp Pharm; 1990 Apr; 47(4):819-20. PubMed ID: 1969712
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of peritoneal membrane permeability by long-term use of neutral-pH peritoneal dialysis solution: a preliminary report in high transporters.
    Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
    Clin Exp Nephrol; 2004 Dec; 8(4):392-3. PubMed ID: 15619044
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysate CA125 levels in stable peritoneal dialysis patients.
    Okada T; Nakao T; Matsumoto H
    Clin Nephrol; 1999 Jan; 51(1):65-6. PubMed ID: 9988153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Composition of amino acid in blood and dialysate by patients with in chronic renal insufficiency by peritoneal dialysis].
    Pichugina IS; Gapparov MM; Chukarina EV; Vetchinnikova ON; Vatazin AV
    Vopr Pitan; 2008; 77(3):45-8. PubMed ID: 18669331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids.
    Frischmann M; Spitzer J; Fünfrocken M; Mittelmaier S; Deckert M; Fichert T; Pischetsrieder M
    Biomed Chromatogr; 2009 Aug; 23(8):843-51. PubMed ID: 19353694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of ethosuximide and phenobarbital by peritoneal dialysis in a child.
    Marquardt ED; Ishisaka DY; Batra KK; Chin B
    Clin Pharm; 1992 Dec; 11(12):1030-1. PubMed ID: 1286553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.